Expression of CD44 by rhabdomyosarcoma: A new prognostic marker?

British Journal of Cancer

Volumn 80, Issue 5-6, 1999, Pages 918-921

  Humphrey, G ^a   Hazel, D L ^a   MacLennan, K ^a   Lewis, I ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

CD44; Prognosis; Rhabdomyosarcoma

Indexed keywords

HERMES ANTIGEN; MONOCLONAL ANTIBODY;

ADOLESCENT; ANTIBODY LABELING; ARTICLE; CANCER REGRESSION; CELL VIABILITY; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; RHABDOMYOSARCOMA; TREATMENT OUTCOME;

ADOLESCENT; ANTIGENS, CD44; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RHABDOMYOSARCOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 0032895031     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690442     Document Type: Article

References (44)

1. Abbasu AM, Chester KA, Talbot IC, Macpherson AS, Boxer G, Forbes A, Malcolm A and Begent R (1993) CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells. Eur J Cancer 14: 1995-2002
2. Anstee DJ, Gardner B, Spring FA, Holmes CH, Simpson KL, Parson SF, Mallinson G, Yousaf SM and Judson PA (1991) New monoclonal antibodies to CD44 and CD58: their use to quantify CD44 and CD58 on normal human erythrocytes and to compare the distribution of CD44 and CD58 in human tissues. Immunology 74: 197-205
3. Arch R, Wirth K, Hofmann M, Ponta H, Matzuka S, Herrlich P and Zoller M (1992) Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257: 682-685
4. Birch M, Mitchell S and Hart IR (1991) Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res 51: 6660-6667
5. Christiansen H, Sahin K, Berthod F, Hero B, Terpe H-J and Lampert F (1995) Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblasfoma. Eur J Cancer 31A: 541-544
6. Culty M, Miyake K, Kineade PW, Silorski E, Butcher EC and Underhill C (1990) The hyaluronate-receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 111: 2765-2774
7. Dall P, Heider KH, Hekele A, van Minckwitz G, Kaufmann M, Ponta H and Herrlich P (1994) Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res 54: 3337-3341
8. Dias P. Kumar P, Marsden HB, Gattamaneni HR, Heighway J and Kumar S (1990) N-myc gene is amplified in alveolar RMS but not embryonal RMS. Int J Cancer 45: 593-596
9. Driman D, Thorner PS, Greenberg ML, Chilton MacNeill S and Squire J (1994) MYCN gene amplification in rhabdomyoscarcoma (RMS). Cancer 73: 2231-2237
10. Favrot MC, Combaret V and Lasset C (1993) CD44 a new prognostic marker for neuroblastoma. N Engl J Med 329: 1965
11. Forsberg UH, Ala-Kapee MM, Jalkanen S, Andersson LC and Schroder J (1989) The gene for human lymphocyte homing receptor is located on chromosome 11. Eur J Immunol 19: 409-412
12. Fujita N, Yacgashi N, Ide Y, Sato S, Nakamura M, Ishiwata I and Yajima A (1994) Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res 54: 3922-3928
13. Gown AM, de Wever N and Battifora H (1993) Microwave-based antigenic unmasking. A revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1: 256-266
14. Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D and Beck D (1994) CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res 54: 4238-4242
15. Gross N, Beck D, Beretta C, Jackson D and Perrusisseau G (1995) CD44 expression and modulation on human neuroblastoma tumours and cell lines. Eur J Cancer 31A: 471-475
16. Günthert U, Hofmann M, Ruddy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H and Herrlich P (1991) A new variant ot glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24
17. Harwood CA, Green MA and Cook MG (1996) CD44 expression in melanocytic lesions: a marker of malignant progression? Br J Dermatol 135: 876-882
18. Heider K-H, Dammrich J, Skroch-Angel P, Müller-Hermelink H-K, Vollmers P, Herrlich P and Ponta H (1993a) Differential expression of CD44 splice variants in intestinal-and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 53: 4197-4203
19. Heider K-H, Hofmann M, Hors E, van den Berg F, Ponta H, Herrlich P and Pals ST (1993b) A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomalous polyps. J Cell Biol 120: 227-233
20. Herrlich P, Zoller M, Pals ST and Ponta H (1993) CD44 splice variant: metastases meet lymphocytes. Immunol Today 14: 395-399
21. Lesley J, Hyman R and Kincade PW (1993) CD44 and its interaction with extracellular matrix. Adv Immunol 54: 271-335
22. Jackson DG, Buckley J and Bell JI (1992) Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 267: 4732-4739
23. Joensuu H, Klemi PJ, Toikkannen S and Jalkanen S (1993) Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol 143: 867-874
24. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P and Pals ST (1993) Activated human lymphocytes and aggressive non-Hodkgin's lymphomas express a homologue of rat metastasis-associated variant of CD44. J Exp Med 177: 897-904
25. Mackay CR, Terpe H-J, Stander R, Marston WL, Stark H and Günther U (1994) Expression and modulation of CD44 variant isoforms in human. J Cell Biol 124: 71-82
26. Mailet MW, Robinson R and Burgart LJ (1992) Genomic alterations in sarcomas: a histologic correlative study with use of oncogene panels. Mod Pathol 5: 410-414
27. Matsumura Y and Tarin D (1992) Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053-1058
28. Matsumura Y, Hanbury D, Smith J and Tarin D (1994) Non invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. Br Med J 308: 619-624
29. Mayer B, Jauch KW, Günthert U, Figdor CG, Schilberg FW, Funke I and Johnson JP (1993) De novo expression of CD44 and survival in gastric cancer. Lancet 342: 1019-1022
30. Nagabhushan M, Pretlow TG, Guo Y-J, Amini SB, Pretlow T and Sy M-S (1996) Altered expression of CD44 in human prostate cancer during progression. Am J Clin Pathol 106: 647-651
31. Newton WA Jr, Gehan EA, Webber BL, Marsden HB, Van Unnik AJ, Hamoudi AB, Tsakos MG, Shimada H, Harms D, Schmidt D, Ninfo V, Cavazzano AO, Gonzalez-Crussi F, Parham DM, Reiman HH, Asmar L, Beltangady MS, Sachs NE, Triche TJ and Maurer HM (1995) Classification of rhabdomyosarcomas and related sarcoms, pathological aspects and proposals for a new classification - an Intergroup Rhabdomyosarcoma Study. Cancer 76: 1073-1085
32. Penno MB, August JT, Baylin ST, Mabry M, Linnala I, Lee VS, Croteau D, Yang XL and Rosada C (1994) Expression of CD44 in human lung tumors. Cancer Res 54: 1381-1387
33. Picker LJ, Nakache M and Butcher EC (1989) Monoclonal antibodies to the human lymphocyte homing receptors dehne a novel class of adhesion molecules on diverse cell types. J Cell Biology 109: 927-937
34. Salmi M, Grön-Virs K, Sointu P, Grenman R, Kalimo H and Jalkanen S (1993) Regulated expression of exon v6 containing isoforms of CD44 in man: down regulalion during malignant transformation of tumors of squamocellular origin. J Cell Biol 122: 432-442
35. Saxon BR, Byard RW and Han P (1997) Cellular expression of adhesion factors in childhood rhabdomyosarcoma. Ped Pathol Lab Med 17: 259-266
36. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U and Bell JI (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spiced exons. Proc Natl Acad Sci USA 89: 12160-12164
37. Shtivelmann E and Bishop JM (1991) Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol 11: 5446-5453
38. Southgate J, Tredjdosiewicz LK, Smith B and Selby PJ (1995) Patterns of splice variant and CD44 expression by normal human urothelium in situ and in vitro and by bladder-carcinoma cell lines. Int J Cancer 62: 449-456
39. Sy MS, Guo YJ and Stamenkovic I (1991) Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174: 859-866
40. Tanabe KK, Ellis LM and Saya H (1993) Expression of CD44RJ adhesion molecule in colon carcinomas and metastases. Lancet 341: 725-726
41. Terpe H-J, Zimmer C, Günthert U and Korf B (1993) CD44-expression in human brain tumors. Clin Neuropathol 12: 271-272
42. Terpe H-J, Christiansen H, Gonzalez M, Berthold F and Lampert F (1995) Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44s. Eur J Cancer 31A: 549-552
43. Tsuda H, Shimosato Y, Upton MP, Yokota J, Terada M, Ohira M, Sugimura T and Hiroshashi S (1988) Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation. Lab Invest 59: 321-327
44. Wielenga VJ, Heider K-H, Offerhaus AJ, Güther R, van den Berg FM, Ponta H, Herrlich P and Pals ST (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53: 4754-4756